Well-being program for adults with irritable bowel syndrome
Tests a well-being program in adults with irritable bowel syndrome.
Key facts
- Who runs it
- University of Wisconsin, Madison
- Where
- Madison, United StatesSee the site
- Trial code
- Registry title
- A Well-Being Intervention for People With IBS
- Status
- Not yet recruiting
- People taking part
- 150 people, planned
- Starts
- Dec 2026
- Expected to end
- Aug 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Well-Being Intervention
- Record updated
- 29 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with Irritable Bowel Syndrome (IBS). It tests a well-being program for mood and IBS symptoms.
- Age
- 18 Years and older
- Sex
- Men and women can join.
- Disease stage
- Currently diagnosed with IBS by a healthcare provider.
- Earlier treatment
- People who took part before in a similar intervention study cannot join.
Main reasons for not taking part
- Thinking (cognitive) problems or reading difficulties that make study materials or questionnaires hard to use
- Not able to give informed consent
- Prior participation in a similar intervention study
- Not speaking, reading and writing English
- Not a UW Health patient and not referred through UW Digestive Health Center
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Men and women currently diagnosed with Irritable Bowel Syndrome (IBS) by a healthcare provider
- Able to read and write in English
- Willing to complete questionnaires and participate in either the intervention or control group
- Capable of providing informed consent
- Must be a UW Health patient or referred through UW Digestive Health Center
Who cannot take part
- Prior participation in a similar intervention study
- Individuals with cognitive impairments or reading difficulties that would interfere with understanding study materials or completing assessments
- Individuals unable to provide informed consent
- Non-English speakers (since study materials are in English)
Where in United States
- UW Health Digestive Health CenterMadison, United StatesContact: Mark Benson, MDNot yet recruiting
About the trial
What the trial wants to find out
The purpose of this randomized behavioral clinical trial is to examine whether a well-being intervention can improve both psychological well-being and physical outcomes in adults with Irritable Bowel Syndrome (IBS). The study aims to assess whether this intervention decreases anger, anxiety, and depression; increases self-esteem, empathy, and hope; and improves quality of life indicators such as IBS symptom severity, sleep quality, fatigue, and diet. Participants can expect to be on study for up to 9 months.
The 2 groups in the trial
- Well-Being InterventionTreatment being tested
- Waitlist Control (delayed Well-Being Intervention)Existing treatment, for comparison
Treatment: Well-Being Intervention
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Well-Being Intervention for People With IBS
- Plain-language title
- Well-being program for adults with irritable bowel syndromeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 29 September 2026